Vitro Diagnostics Inc

(VODG)

By |

Profile

Vitro Diagnostics, Inc., was incorporated under the laws of the State of Nevada on February 3, 1986. Its operations are currently focused on development, manufacturing and distribution of stem cell products and related tools for use in research and drug discovery. Its current focus is the development and commercialization of new products derived from its stem cell research. The Company presently develops, manufactures and markets products for use in research and related applications that do not require approval of the United States Food and Drug Administration ('FDA') prior to market introduction. It has previously developed products and product candidates for treatment of infertility. The Company's stem cell technology includes cell lines, supporting products and methods for generation and differentiation of stem cells into products with application to treatment of numerous diseases such as heart disease, stroke, Parkinson's and Alzheimer's disease. The Company has also developed patented and patent-pending technology for use in stem cell research, drug development and therapeutic products for treatment of cancer and diabetes. Modern stem cell technology is rapidly evolving towards commercialization and holds promise to revolution medicine by allowing replacement of any type of cell within the human body. Present suppliers of human stem cells and related products include In-Vitrogen, Millipore, Stem Cell Technologies and several other firms. The Company's technology related to the production of cell culture media is protected as trade secret. It faces competition from a number of larger, well-established entities in the area of fertility treatment. The Company has established trademark claims to its VITROPIN product informally by publication.

Contact Information

Website: www.vitrobiopharma.com
Email: jim@vitrodiag.com
Main Phone: +1 303 999-2130
Address: 4621 Technology Drive
State: CO
City / Town: Golden
Country: USA
Postal Code: 80403

Issuer Information

Exchange: OTO
CEO: James R. Musick
Employees: 2
NAICS: In-Vitro Diagnostic Substance Manufacturing(325413)
$ 0.25 $ 0.00805 (3.33%)
Last Price 0.25 Change $ 0.00805 Change % 3.33 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 0.25 High 0.25 Low 0.25 Prev Close 0.24
Last Trade Volume 5,000 52 Wk Hi 0.45 52 Wk Low 0.03
Market Cap 5.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 20,391,822.00 EPS (TTM) -0.02 PE Ratio N/A Exchange OTCPK
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
James Musick 1,000
James Musick 1,000
Last 10 Sell Shares
James Musick 1,000
James Musick 1,000
James Musick 1,000
James Musick 1,000
James Musick 1,000
James Musick 1,000
James Musick 1,000
James Musick 1,000
James Musick 1,000